Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.88 USD | +2.26% | +0.57% | -38.37% |
Financials (USD)
Sales 2024 * | 137M | Sales 2025 * | 215M | Capitalization | 4.49B |
---|---|---|---|---|---|
Net income 2024 * | -613M | Net income 2025 * | -584M | EV / Sales 2024 * | 43 x |
Net Debt 2024 * | 1.42B | Net Debt 2025 * | 1.25B | EV / Sales 2025 * | 26.6 x |
P/E ratio 2024 * |
-7.55
x | P/E ratio 2025 * |
-7.77
x | Employees | 553 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.27% |
Latest transcript on BridgeBio Pharma, Inc.
1 day | -2.80% | ||
1 week | -2.48% | ||
Current month | -21.31% | ||
1 month | -17.22% | ||
3 months | -32.55% | ||
6 months | -0.41% | ||
Current year | -39.73% |
Managers | Title | Age | Since |
---|---|---|---|
Neil Kumar
FOU | Founder | 45 | 14-12-31 |
Charles Homcy
FOU | Founder | 75 | 14-12-31 |
Founder | 73 | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 16-02-29 |
Founder | 73 | 14-12-31 | |
Fred Hassan
BRD | Director/Board Member | 78 | 21-08-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.35% | 2 M€ | -.--% | ||
0.12% | 7 M€ | -.--% | - | |
0.11% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 24.88 | +2.26% | 1 049 016 |
24-04-25 | 24.33 | -2.80% | 1,759,684 |
24-04-24 | 25.03 | -1.69% | 1,540,280 |
24-04-23 | 25.46 | +1.56% | 1,223,615 |
24-04-22 | 25.07 | +1.33% | 2,123,116 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.73% | 4.49B | |
-4.66% | 87.53B | |
+2.63% | 40.42B | |
-21.76% | 29.48B | |
+56.02% | 25.43B | |
-14.78% | 15.59B | |
-18.49% | 11.49B | |
-15.61% | 11.1B | |
-44.02% | 11.3B | |
+4.42% | 8.75B |
- Stock Market
- Equities
- BBIO Stock